Showing results (1821-1830 of 2,769) with videos related to

Sort By:
Pageof 277
Molecular Ecology|October 22, 2021
Population genomic, olfactory, dietary, and gut microbiota analyses demonstrate the unique evolutionary trajectory of feral pigsSimona Petrelli, Maria Buglione, Valeria Maselli, et al.
Journal of Pediatric Surgery|February 9, 2021
Ten-year experience with staged management of pectus carinatum: Results and lessons learnedKelly Robert Edward, Obermeyer Robert John, Goretsky Michael Jay, et al.
Chest|September 11, 2022
Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension: Insights From the Randomized Controlled Study With Selexipag (TRACE)Luke S Howard, Stephan Rosenkranz, Robert P Frantz, et al.
Frontiers in Immunology|September 21, 2018
CD18 Regulates Monocyte Hematopoiesis and Promotes Resistance to Experimental SchistosomiasisCamila O S Souza, Milena S Espíndola, Caroline Fontanari, et al.
Open Heart|July 19, 2018
Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry diseaseDan Liu, Daniel Oder, Tim Salinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2017
Deletion of Gas2l3 in mice leads to specific defects in cardiomyocyte cytokinesis during developmentSabine Stopp, Marco Gründl, Marc Fackler, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 31, 2011
Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandinsC Peres-Buzalaf, L de Paula, F G Frantz, et al.
Journal of Clinical Pathology|April 29, 2004
Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumoursA M Jubb, T Q Pham, A M Hanby, et al.
The EMBO Journal|February 15, 1994
Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa BB Frantz, E C Nordby, G Bren, et al.
Journal of the American Society of Nephrology : JASN|September 5, 2009
Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidusFrédéric Jean-Alphonse, Sanja Perkovska, Marie-Céline Frantz, et al.
Pageof 277